HN30

Research HN30 on Bullrun: market cap EUR 2.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHN30
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 2.91M
• Financial periodQ4 2025
• Net income-EUR 157.32K
• Free cash flow-EUR 325.52K

Valuation Snapshot

latest market cap is EUR 2.91M.

About HN30

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products.

Frequently asked questions

What is HN30's market cap?

HN30's market capitalization is EUR 2.91M.

What does HN30 do?

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products.